Back to Newsroom

Symic Biomedical Appoints Kamal Egodage, Ph.D., MBA, VP of Development & Manufacturing and Grace Wong-Sarad, VP and Controller

SAN FRANCISCO, Nov. 5, 2015​– Symic Biomedical, a clinical-stage biotherapeutics company developing multiple compounds that target the extracellular matrix (ECM), today announced the appointment of Kamal Egodage, Ph.D., MBA, as Vice President of Development & Manufacturing and Grace Wong-Sarad as Vice President and Controller.

Click here to read more